首页 > 最新文献

Journal of the Canadian Association of Gastroenterology最新文献

英文 中文
Contemporary epidemiology of hepatocellular carcinoma: understanding risk factors and surveillance strategies 肝细胞癌的当代流行病学:了解风险因素和监控策略
Pub Date : 2024-08-09 DOI: 10.1093/jcag/gwae025
F. Jaber, G. Cholankeril, H. El‐Serag
The contemporary epidemiology of hepatocellular carcinoma (HCC) shows a shift in the main etiological risk factors from less common but highly virulent (eg, hepatitis C and B) to more common but weak risk factors (eg, alcohol and metabolic syndrome). Therefore, we are in a seemingly paradoxical state of declining overall incidence rates of HCC-related to improved prevention and treatment of viral hepatitis but burgeoning number of people at an elevated risk of HCC. Several geographic regions have reported an increase in HCC attributable to alcoholic liver disease and metabolic dysfunction associated with steatotic liver disease (MASLD). The importance of risk stratification is increasing to allow for targeted prevention and early detection of HCC. Most risk factors predispose HCC through the formation of cirrhosis, which has served as the main risk stratifying factor. However, this scheme is showing cracks at both ends of the spectrum. On one hand, the risk of developing HCC varies widely among patients with contemporary advanced fibrosis or cirrhosis, and on the other hand up to one-third of MASLD-related HCC occurs among patients with no clear evidence of cirrhosis. The use of multidimensional (eg, clinical, epidemiological, and biochemical) predictive algorithms may improve risk stratification efforts. The shift in HCC risk factors also further heightened the importance and limitations of current surveillance practices (eg, reduced performance of ultrasound in MASLD). Therefore, exploring advanced imaging methods, new biomarkers but also existing combinations of biomarkers augmented by clinical factors for HCC early detection is crucial.
当代肝细胞癌(HCC)的流行病学显示,主要的致病风险因素正在从较少见但毒性较强的因素(如丙型肝炎和乙型肝炎)向较常见但风险较弱的因素(如酒精和代谢综合征)转变。因此,我们正处于一种看似矛盾的状态:HCC 的总体发病率下降与病毒性肝炎预防和治疗的改善有关,但 HCC 高危人群的数量却在激增。一些地区报告称,酒精性肝病和脂肪性肝病相关代谢功能障碍 (MASLD) 导致的 HCC 有所增加。为了有针对性地预防和早期发现 HCC,风险分层的重要性与日俱增。大多数风险因素通过肝硬化的形成诱发 HCC,而肝硬化一直是主要的风险分层因素。然而,这一方案在两端都出现了裂缝。一方面,当代晚期纤维化或肝硬化患者罹患 HCC 的风险差异很大,另一方面,多达三分之一的 MASLD 相关 HCC 发生在没有明确肝硬化证据的患者中。使用多维(如临床、流行病学和生化)预测算法可改善风险分层工作。HCC 风险因素的变化也进一步提高了当前监测方法的重要性和局限性(例如,MASLD 中超声波的性能降低)。因此,探索先进的成像方法、新的生物标志物以及现有的生物标志物组合并辅以临床因素进行 HCC 早期检测至关重要。
{"title":"Contemporary epidemiology of hepatocellular carcinoma: understanding risk factors and surveillance strategies","authors":"F. Jaber, G. Cholankeril, H. El‐Serag","doi":"10.1093/jcag/gwae025","DOIUrl":"https://doi.org/10.1093/jcag/gwae025","url":null,"abstract":"\u0000 The contemporary epidemiology of hepatocellular carcinoma (HCC) shows a shift in the main etiological risk factors from less common but highly virulent (eg, hepatitis C and B) to more common but weak risk factors (eg, alcohol and metabolic syndrome). Therefore, we are in a seemingly paradoxical state of declining overall incidence rates of HCC-related to improved prevention and treatment of viral hepatitis but burgeoning number of people at an elevated risk of HCC. Several geographic regions have reported an increase in HCC attributable to alcoholic liver disease and metabolic dysfunction associated with steatotic liver disease (MASLD). The importance of risk stratification is increasing to allow for targeted prevention and early detection of HCC. Most risk factors predispose HCC through the formation of cirrhosis, which has served as the main risk stratifying factor. However, this scheme is showing cracks at both ends of the spectrum. On one hand, the risk of developing HCC varies widely among patients with contemporary advanced fibrosis or cirrhosis, and on the other hand up to one-third of MASLD-related HCC occurs among patients with no clear evidence of cirrhosis. The use of multidimensional (eg, clinical, epidemiological, and biochemical) predictive algorithms may improve risk stratification efforts. The shift in HCC risk factors also further heightened the importance and limitations of current surveillance practices (eg, reduced performance of ultrasound in MASLD). Therefore, exploring advanced imaging methods, new biomarkers but also existing combinations of biomarkers augmented by clinical factors for HCC early detection is crucial.","PeriodicalId":508018,"journal":{"name":"Journal of the Canadian Association of Gastroenterology","volume":"14 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-08-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141925007","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Identification and prioritization of patient-centred strategies to enhance IBD-related care for older adults: a modified Delphi approach 确定和优先考虑以患者为中心的战略,以加强对老年人的 IBD 相关护理:改良德尔菲法
Pub Date : 2024-07-06 DOI: 10.1093/jcag/gwae021
N. Rohatinsky, Natasha Tooke, S. Fowler, Christian Rueda-Clausen, Dirk Morrison, Judith Winchester, J. Peña-Sánchez
The older adult age group makes up one of the fastest-growing groups of individuals with inflammatory bowel disease (IBD). It is important to hear the perspectives of older adults living with IBD about care experiences and managing their illness. The purpose of this patient-oriented study was to identify and prioritize patient-centred strategies that have the potential to enhance IBD-related care for older adults in Saskatchewan. The interprofessional research team, consisting of older adult individuals living with IBD, gastroenterology providers, and researchers specializing in IBD or older adult education used a modified Delphi approach to identify and prioritize strategies that may enhance IBD-related care for older adults. Thirty-one older adults with IBD participated in ranking, revising, and prioritizing statements related to their chronic illness care. Nine statements were developed that highlighted strategies for older adult IBD care. Through the consensus process, 6 statements were retained. Co-creating a treatment plan with the IBD provider was ranked as the top priority statement for older adults with IBD. Facilitating collaborative relationships and understanding individual priorities for IBD-related care for older adults has the potential to enhance positive health outcomes and quality of life for these individuals.
老年人是炎症性肠病 (IBD) 患者中增长最快的群体之一。听取患有 IBD 的老年人对护理经验和疾病管理的看法非常重要。这项以患者为导向的研究旨在确定和优先考虑以患者为中心的策略,这些策略有可能加强萨斯喀彻温省老年人的 IBD 相关护理。 跨专业研究小组由患有 IBD 的老年人、肠胃病医生以及 IBD 或老年人教育方面的专业研究人员组成,他们采用改良的德尔菲法来确定并优先考虑可加强老年人 IBD 相关护理的策略。31 名患有 IBD 的老年人参与了与其慢性病护理相关的陈述的排序、修改和优先排序。最终形成了 9 项声明,强调了老年人 IBD 护理策略。 在达成共识的过程中,保留了 6 项陈述。与 IBD 提供者共同制定治疗计划被列为 IBD 老年患者的首要任务。 促进合作关系并了解老年人 IBD 相关护理的个人优先事项,有可能提高这些人的积极健康结果和生活质量。
{"title":"Identification and prioritization of patient-centred strategies to enhance IBD-related care for older adults: a modified Delphi approach","authors":"N. Rohatinsky, Natasha Tooke, S. Fowler, Christian Rueda-Clausen, Dirk Morrison, Judith Winchester, J. Peña-Sánchez","doi":"10.1093/jcag/gwae021","DOIUrl":"https://doi.org/10.1093/jcag/gwae021","url":null,"abstract":"\u0000 \u0000 \u0000 The older adult age group makes up one of the fastest-growing groups of individuals with inflammatory bowel disease (IBD). It is important to hear the perspectives of older adults living with IBD about care experiences and managing their illness. The purpose of this patient-oriented study was to identify and prioritize patient-centred strategies that have the potential to enhance IBD-related care for older adults in Saskatchewan.\u0000 \u0000 \u0000 \u0000 The interprofessional research team, consisting of older adult individuals living with IBD, gastroenterology providers, and researchers specializing in IBD or older adult education used a modified Delphi approach to identify and prioritize strategies that may enhance IBD-related care for older adults. Thirty-one older adults with IBD participated in ranking, revising, and prioritizing statements related to their chronic illness care. Nine statements were developed that highlighted strategies for older adult IBD care.\u0000 \u0000 \u0000 \u0000 Through the consensus process, 6 statements were retained. Co-creating a treatment plan with the IBD provider was ranked as the top priority statement for older adults with IBD.\u0000 \u0000 \u0000 \u0000 Facilitating collaborative relationships and understanding individual priorities for IBD-related care for older adults has the potential to enhance positive health outcomes and quality of life for these individuals.\u0000","PeriodicalId":508018,"journal":{"name":"Journal of the Canadian Association of Gastroenterology","volume":" 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141672690","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rectal varices treated by retrograde transvenous obliteration 通过逆行经静脉阻塞治疗直肠静脉曲张
Pub Date : 2024-05-10 DOI: 10.1093/jcag/gwae016
L. Rioux, Laurence Dubé, Lauren Said
{"title":"Rectal varices treated by retrograde transvenous obliteration","authors":"L. Rioux, Laurence Dubé, Lauren Said","doi":"10.1093/jcag/gwae016","DOIUrl":"https://doi.org/10.1093/jcag/gwae016","url":null,"abstract":"","PeriodicalId":508018,"journal":{"name":"Journal of the Canadian Association of Gastroenterology","volume":" 7","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140993941","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Canadian colorectal cancer screening programs: How do they measure up using the International Agency for Research on Cancer criteria for organized screening? 加拿大大肠癌筛查计划:根据国际癌症研究机构的有组织筛查标准,这些计划的效果如何?
Pub Date : 2024-05-01 DOI: 10.1093/jcag/gwae015
Cindy C Y Law, Li Zhang, A. L. Carvalho, Linda Rabeneck, Alan N. Barkun, Anja Nied-Kutterer, David Armstrong, Clarence K Wong, Diane Lamothe, Donald Macintosh, Catherine Dubé, E. Kilfoil, Jennifer Telford, Nancy N. Baxter, Eshwar Kumar, H. Singh, J. Mcgrath, Laura Coulter, Daniel C Sadowski, Karen Efthimiou, Hendrik DuPlessis, Kelly Bunzeluk, L. Gentile, M. Guertin, B. McCurdy, Michael Kohle, Michael Stewart, Ross Stimpson, S. Antle, Shelley Polos, S. Heitman, Tong Zhu, Simbi Ebenuwah, Judy Kosloski, Melissa Mok, Partha Basu, J. Tinmouth
Canada has one of the highest incidences of colorectal cancer (CRC) worldwide. CRC screening improves CRC outcomes and is cost-effective. This study compares Canadian CRC screening programs using essential elements of an organized screening program outlined by the International Agency for Research on Cancer (IARC). We collaborated with the Cancer Screening in 5 continents (CanScreen5) program, an initiative of IARC. Standardized data collection forms were sent to representatives of provincial and territorial CRC screening programs. Twenty-five questions were selected to reflect IARC’s essential elements of an organized screening program. We performed a qualitative analysis of Canada’s CRC screening programs and compared programs within Canada and internationally. CRC screening programs exist in 10 provinces and 2 territories. None of the programs in Canada met all the essential criteria of an organized screening program outlined by IARC. Three programs do not send invitations to participate in screening. Among those that do, 4 programs do not include a stool test kit in the invitations. While all provinces met the essential elements for leadership, governance, finance, and access to essential services, there was more heterogeneity in the domains of service delivery as well as information systems and quality assurance. There is considerable heterogeneity in the design of CRC screening programs in Canada and worldwide. Programs should strive to meet all the essential IARC criteria for organized screening if local resources allow, such as issuing invitations and implementing systems to track and compare outcomes to maximize screening program quality, effectiveness, and impact.
加拿大是全球大肠癌(CRC)发病率最高的国家之一。CRC 筛查可改善 CRC 的治疗效果,而且具有成本效益。本研究采用国际癌症研究机构(IARC)概述的有组织筛查计划的基本要素,对加拿大的 CRC 筛查计划进行了比较。 我们与国际癌症研究机构发起的五大洲癌症筛查(CanScreen5)计划进行了合作。我们向各省和地区的 CRC 筛查项目代表发送了标准化的数据收集表。我们选择了 25 个问题来反映 IARC 提出的有组织筛查计划的基本要素。我们对加拿大的 CRC 筛查计划进行了定性分析,并对加拿大国内和国际上的计划进行了比较。 加拿大有 10 个省和 2 个地区实施了 CRC 筛查计划。加拿大没有任何一项筛查计划符合 IARC 提出的有组织筛查计划的所有基本标准。有三个项目没有发出参加筛查的邀请。在发出邀请的计划中,有 4 个计划的邀请函中不包括粪便检测试剂盒。虽然所有省份都符合领导力、管理、财务和获得基本服务的基本要素,但在提供服务以及信息系统和质量保证等领域存在更多差异。 加拿大和世界范围内的 CRC 筛查项目在设计上存在很大差异。在当地资源允许的情况下,筛查计划应努力满足 IARC 关于有组织筛查的所有基本标准,如发出邀请、实施跟踪和比较结果的系统,以最大限度地提高筛查计划的质量、有效性和影响力。
{"title":"Canadian colorectal cancer screening programs: How do they measure up using the International Agency for Research on Cancer criteria for organized screening?","authors":"Cindy C Y Law, Li Zhang, A. L. Carvalho, Linda Rabeneck, Alan N. Barkun, Anja Nied-Kutterer, David Armstrong, Clarence K Wong, Diane Lamothe, Donald Macintosh, Catherine Dubé, E. Kilfoil, Jennifer Telford, Nancy N. Baxter, Eshwar Kumar, H. Singh, J. Mcgrath, Laura Coulter, Daniel C Sadowski, Karen Efthimiou, Hendrik DuPlessis, Kelly Bunzeluk, L. Gentile, M. Guertin, B. McCurdy, Michael Kohle, Michael Stewart, Ross Stimpson, S. Antle, Shelley Polos, S. Heitman, Tong Zhu, Simbi Ebenuwah, Judy Kosloski, Melissa Mok, Partha Basu, J. Tinmouth","doi":"10.1093/jcag/gwae015","DOIUrl":"https://doi.org/10.1093/jcag/gwae015","url":null,"abstract":"\u0000 \u0000 \u0000 Canada has one of the highest incidences of colorectal cancer (CRC) worldwide. CRC screening improves CRC outcomes and is cost-effective. This study compares Canadian CRC screening programs using essential elements of an organized screening program outlined by the International Agency for Research on Cancer (IARC).\u0000 \u0000 \u0000 \u0000 We collaborated with the Cancer Screening in 5 continents (CanScreen5) program, an initiative of IARC. Standardized data collection forms were sent to representatives of provincial and territorial CRC screening programs. Twenty-five questions were selected to reflect IARC’s essential elements of an organized screening program. We performed a qualitative analysis of Canada’s CRC screening programs and compared programs within Canada and internationally.\u0000 \u0000 \u0000 \u0000 CRC screening programs exist in 10 provinces and 2 territories. None of the programs in Canada met all the essential criteria of an organized screening program outlined by IARC. Three programs do not send invitations to participate in screening. Among those that do, 4 programs do not include a stool test kit in the invitations. While all provinces met the essential elements for leadership, governance, finance, and access to essential services, there was more heterogeneity in the domains of service delivery as well as information systems and quality assurance.\u0000 \u0000 \u0000 \u0000 There is considerable heterogeneity in the design of CRC screening programs in Canada and worldwide. Programs should strive to meet all the essential IARC criteria for organized screening if local resources allow, such as issuing invitations and implementing systems to track and compare outcomes to maximize screening program quality, effectiveness, and impact.\u0000","PeriodicalId":508018,"journal":{"name":"Journal of the Canadian Association of Gastroenterology","volume":"2 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141053957","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A88 ADVERSE EVENTS ASSOCIATED WITH ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY: A SYSTEMATIC REVIEW AND META-ANALYSIS A88 与内镜逆行胰胆管造影术相关的不良事件:系统回顾与荟萃分析
Pub Date : 2024-02-14 DOI: 10.1093/jcag/gwad061.088
H. Guo, K. Bishay, Z. Meng, Y. Ruan, D. Brenner, N. Forbes
Abstract Background Endoscopic retrograde cholangiopancreatography (ERCP) is a widely utilized procedure for diagnosing and managing various biliary and pancreatic disorders. Despite its established effectiveness, ERCP is associated with a total adverse event (AE) rate exceeding 10%. However, existing literature lacks a comprehensive synthesis of incidence rates pertaining to specific or overall AEs following ERCP procedures. Aims We performed separate systematic reviews and meta-analyses of (1) data from randomized controlled trials (RCTs) and (2) data from observational studies to evaluate the incidence of AEs following ERCPs in adult patients. Methods Two separate systematic literature searches were conducted to identify ERCP AE rates in RCTs and observational studies published between 2000 and 2021, inclusive. Abstracts underwent independent assessment to identify studies for full-text review and subsequent data extraction. DerSimonian and Laird random effects meta-analyses were applied to determine pooled incidence rates of individual post-ERCP AEs, accompanied by 95% confidence intervals (CIs). The Newcastle-Ottawa Scale (NOS) and Risk of Bias 2 (ROB2) tool were used for quality assessment of observational studies and RCTs respectively. Results Our analysis incorporated 242 RCTs and 143 observational studies. Among RCTs, the pooled incidences of post-ERCP pancreatitis (PEP) in patients with native and non-native papillae were 6.9% (CI 6.2% to 7.6%) and 6.1% (CI 5.3% to 7.1%), respectively. In observational studies, the pooled PEP incidences were 5.0% (CI 4.0% to 6.1%) for patients with native papillae and 4.2% (CI 3.6% to 4.8%) for patients with non-native papillae. The incidences of bleeding for patients with native papillae were 1.6% (CI 1.3% to 2.0%) and 2.2% (CI 1.2% to 3.9%) in RCTs and observational studies, respectively. The incidences of perforation for patients with native papillae were 0.3% (CI 0.2% to 0.4%) in RCTs and 0.5% (CI 0.3% to 0.7%) in observational studies. The incidence of cholangitis was 1.4% (CI 1.1% to 1.9%) in RCTs and 1.1% (CI 0.7% to 1.7%) in observational studies. Conclusions This meta-analysis offers comprehensive insights into the incidence of ERCP-associated AEs from 2000 to 2021, both in idealized study settings where procedures are performed by experts, and in ‘real world’ settings. More precise estimates of ERCP-related AEs can help facilitate patient consent, manage appropriate patient expectations, and enhance peri-procedural care. Funding Agencies None
摘要 背景 内镜逆行胰胆管造影术(ERCP)被广泛用于诊断和治疗各种胆道和胰腺疾病。尽管ERCP具有公认的有效性,但其总不良事件(AE)发生率超过10%。然而,现有文献缺乏对ERCP术后特定或总体不良事件发生率的全面综述。目的 我们分别对(1)随机对照试验(RCT)的数据和(2)观察性研究的数据进行了系统综述和荟萃分析,以评估成人患者ERCP术后AE的发生率。方法 分别进行了两次系统性文献检索,以确定 2000 年至 2021 年(含 2021 年)期间发表的随机对照试验和观察性研究中 ERCP AE 的发生率。对摘要进行独立评估,以确定进行全文审阅和后续数据提取的研究。采用 DerSimonian 和 Laird 随机效应荟萃分析来确定 ERCP 后各 AE 的汇总发病率,并附有 95% 的置信区间 (CI)。纽卡斯尔-渥太华量表 (NOS) 和偏倚风险 2 (ROB2) 工具分别用于观察性研究和 RCT 的质量评估。结果 我们的分析纳入了 242 项研究性试验和 143 项观察性研究。在研究性临床试验中,原生乳头和非原生乳头患者ERCP术后胰腺炎(PEP)的总发病率分别为6.9%(CI为6.2%至7.6%)和6.1%(CI为5.3%至7.1%)。在观察性研究中,原生乳头患者的PEP总发生率为5.0%(CI为4.0%至6.1%),非原生乳头患者的PEP总发生率为4.2%(CI为3.6%至4.8%)。在RCT和观察性研究中,原生乳头患者的出血发生率分别为1.6%(CI为1.3%至2.0%)和2.2%(CI为1.2%至3.9%)。在研究性试验和观察性研究中,原生乳头患者的穿孔发生率分别为 0.3% (CI 0.2% 至 0.4%)和 0.5% (CI 0.3% 至 0.7%)。胆管炎的发生率在研究性试验中为 1.4% (CI 1.1% 至 1.9%),在观察性研究中为 1.1% (CI 0.7% 至 1.7%)。结论 该荟萃分析全面揭示了2000年至2021年ERCP相关AE的发生率,既包括由专家实施手术的理想化研究环境,也包括 "真实世界 "环境。对ERCP相关AEs进行更精确的估计有助于促进患者同意、管理适当的患者期望值并加强围手术期护理。资助机构 无
{"title":"A88 ADVERSE EVENTS ASSOCIATED WITH ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY: A SYSTEMATIC REVIEW AND META-ANALYSIS","authors":"H. Guo, K. Bishay, Z. Meng, Y. Ruan, D. Brenner, N. Forbes","doi":"10.1093/jcag/gwad061.088","DOIUrl":"https://doi.org/10.1093/jcag/gwad061.088","url":null,"abstract":"Abstract Background Endoscopic retrograde cholangiopancreatography (ERCP) is a widely utilized procedure for diagnosing and managing various biliary and pancreatic disorders. Despite its established effectiveness, ERCP is associated with a total adverse event (AE) rate exceeding 10%. However, existing literature lacks a comprehensive synthesis of incidence rates pertaining to specific or overall AEs following ERCP procedures. Aims We performed separate systematic reviews and meta-analyses of (1) data from randomized controlled trials (RCTs) and (2) data from observational studies to evaluate the incidence of AEs following ERCPs in adult patients. Methods Two separate systematic literature searches were conducted to identify ERCP AE rates in RCTs and observational studies published between 2000 and 2021, inclusive. Abstracts underwent independent assessment to identify studies for full-text review and subsequent data extraction. DerSimonian and Laird random effects meta-analyses were applied to determine pooled incidence rates of individual post-ERCP AEs, accompanied by 95% confidence intervals (CIs). The Newcastle-Ottawa Scale (NOS) and Risk of Bias 2 (ROB2) tool were used for quality assessment of observational studies and RCTs respectively. Results Our analysis incorporated 242 RCTs and 143 observational studies. Among RCTs, the pooled incidences of post-ERCP pancreatitis (PEP) in patients with native and non-native papillae were 6.9% (CI 6.2% to 7.6%) and 6.1% (CI 5.3% to 7.1%), respectively. In observational studies, the pooled PEP incidences were 5.0% (CI 4.0% to 6.1%) for patients with native papillae and 4.2% (CI 3.6% to 4.8%) for patients with non-native papillae. The incidences of bleeding for patients with native papillae were 1.6% (CI 1.3% to 2.0%) and 2.2% (CI 1.2% to 3.9%) in RCTs and observational studies, respectively. The incidences of perforation for patients with native papillae were 0.3% (CI 0.2% to 0.4%) in RCTs and 0.5% (CI 0.3% to 0.7%) in observational studies. The incidence of cholangitis was 1.4% (CI 1.1% to 1.9%) in RCTs and 1.1% (CI 0.7% to 1.7%) in observational studies. Conclusions This meta-analysis offers comprehensive insights into the incidence of ERCP-associated AEs from 2000 to 2021, both in idealized study settings where procedures are performed by experts, and in ‘real world’ settings. More precise estimates of ERCP-related AEs can help facilitate patient consent, manage appropriate patient expectations, and enhance peri-procedural care. Funding Agencies None","PeriodicalId":508018,"journal":{"name":"Journal of the Canadian Association of Gastroenterology","volume":"22 2","pages":"62 - 63"},"PeriodicalIF":0.0,"publicationDate":"2024-02-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139777627","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A272 EFFECTS OF EMPAGLIFLOZIN ON CHEMICALLY INDUCED COLITIS IN A MOUSE MODEL ARE MODULATED BY SEX AND DIETARY INTERACTIONS A272 Empagliflozin 对小鼠模型中化学诱导的结肠炎的影响受性别和饮食相互作用的调节
Pub Date : 2024-02-14 DOI: 10.1093/jcag/gwad061.272
K. Madsen, B. Villaflor, N. Hotte, A. Thiesen, C Cheng, T. Omeltchenko
Abstract Background High sugar diets have been shown to dramatically increase disease severity in mouse models of colitis. Empagliflozin (EMPA) is a highly selective sodium glucose cotransporter-2 (SGLT2) inhibitor that is used therapeutically as an antihyperglycemic agent in the management of type 2 diabetes. In human trials EMPA treatment exerts potent anti-inflammatory effects independently of glycemic control. Further, we have previously demonstrated in a genetic mouse model of colitis that EMPA treatment was highly effective in improving colonic inflammation. Based on these findings, we hypothesized that EMPA treatment may also be effective in mitigating disease severity in chemically induced colitis in mice fed a high sugar diet. Aims The aim of this study was to examine the effects of treatment with EMPA on chemically induced colitis in mice fed a high sugar diet Methods At 6-8 weeks of age, wild-type 129/SvEv mice were placed on chow (CH) or high sugar diet (HS) (50% sucrose: AIN76A) ± EMPA (10mg/kg). After two days on the diet, mice were administered dextran sodium sulfate (DSS) for 5 days in drinking water followed by water alone for 2 days (n=4-6 mice for all groups). Disease activity index (DAI) was calculated daily from animal weight change, stool consistency, and stool hemoccult. As a measurement of degree of healing, colonic tissues were evaluated at day 9 for histological changes, weight-to-length ratio, and cytokine levels by ELISA. As a measure of EMPA functionality, urinary and blood glucose levels were measured. Results Mice on the HS diet demonstrated increased susceptibility to colitis compared with chow fed mice with increased colonic levels of IL-1β, weight loss, and DAI. Significant interactions between sex and diet were seen in responses to EMPA treatment. EMPA treatment did not alter severity of colitis but did significantly delay healing in male mice on both the HS and chow diets as evidenced by increased DAI and increased enterocyte injury with increased levels of lamina propria neutrophils and lymphocytes. EMPA treatment did not increase disease severity in females on either diet. No differences were seen in colonic TNFα, IL-10, IL-12p70, or IL-22 between any of the groups. Urinary glucose levels were elevated in mice receiving EMPA and significantly higher in males compared with females (pampersand:003C0.05). EMPA treatment did not alter fasting blood glucose levels. Conclusions A high sugar diet strongly exacerbates disease severity in a sex-dependent manner in a chemically induced model of colitis. Further, contrary to our hypothesis, EMPA treatment did not improve colitis in females and worsened disease in males suggesting that the documented anti-inflammatory effects of EMPA may be condition dependent. Funding Agencies CCC
摘要 背景 研究表明,在结肠炎小鼠模型中,高糖饮食会显著增加疾病的严重程度。恩格列净(Empagliflozin,EMPA)是一种高选择性钠葡萄糖共转运体-2(SGLT2)抑制剂,是治疗2型糖尿病的降糖药物。在人体试验中,EMPA 可在控制血糖的同时发挥强效抗炎作用。此外,我们曾在小鼠结肠炎遗传模型中证实,EMPA 治疗对改善结肠炎症非常有效。基于这些研究结果,我们推测 EMPA 治疗也能有效减轻化学诱导的高糖饮食小鼠结肠炎的病情严重程度。目的 本研究的目的是检测 EMPA 治疗对以高糖饮食喂养的小鼠化学诱导结肠炎的影响 方法 在野生型 129/SvEv 小鼠 6-8 周大时,将其置于饲料(CH)或高糖饮食(HS)(50%蔗糖:AIN76A)± EMPA(10 毫克/千克)饮食中。喂食两天后,给小鼠在饮用水中添加右旋糖酐硫酸钠(DSS)5 天,然后单独喂水 2 天(各组均为 4-6 只小鼠)。每天根据动物体重变化、粪便稠度和粪便血凝块计算疾病活动指数(DAI)。在第 9 天评估结肠组织的组织学变化、重量-长度比和 ELISA 检测的细胞因子水平,以衡量愈合程度。作为 EMPA 功能的衡量标准,测量了尿糖和血糖水平。结果 与饲料喂养的小鼠相比,HS 食物喂养的小鼠结肠炎易感性增加,结肠中 IL-1β 水平、体重减轻和 DAI 增加。在对EMPA治疗的反应中,性别和饮食之间存在显著的交互作用。EMPA治疗不会改变结肠炎的严重程度,但会显著延迟HS和饲料喂养雄性小鼠的愈合,这表现在DAI增加、肠细胞损伤加重以及固有层中性粒细胞和淋巴细胞水平升高。使用两种饲料的雌性小鼠在接受 EMPA 治疗后,疾病的严重程度都没有增加。各组之间的结肠 TNFα、IL-10、IL-12p70 或 IL-22 均无差异。接受EMPA治疗的小鼠尿糖水平升高,雄性小鼠的尿糖水平显著高于雌性小鼠(pampersand:003C0.05)。EMPA 治疗不会改变空腹血糖水平。结论 在化学诱导的结肠炎模型中,高糖饮食以性别依赖的方式严重加剧了疾病的严重程度。此外,与我们的假设相反,EMPA治疗并不能改善女性结肠炎的病情,反而会加重男性结肠炎的病情。资助机构 CCC
{"title":"A272 EFFECTS OF EMPAGLIFLOZIN ON CHEMICALLY INDUCED COLITIS IN A MOUSE MODEL ARE MODULATED BY SEX AND DIETARY INTERACTIONS","authors":"K. Madsen, B. Villaflor, N. Hotte, A. Thiesen, C Cheng, T. Omeltchenko","doi":"10.1093/jcag/gwad061.272","DOIUrl":"https://doi.org/10.1093/jcag/gwad061.272","url":null,"abstract":"Abstract Background High sugar diets have been shown to dramatically increase disease severity in mouse models of colitis. Empagliflozin (EMPA) is a highly selective sodium glucose cotransporter-2 (SGLT2) inhibitor that is used therapeutically as an antihyperglycemic agent in the management of type 2 diabetes. In human trials EMPA treatment exerts potent anti-inflammatory effects independently of glycemic control. Further, we have previously demonstrated in a genetic mouse model of colitis that EMPA treatment was highly effective in improving colonic inflammation. Based on these findings, we hypothesized that EMPA treatment may also be effective in mitigating disease severity in chemically induced colitis in mice fed a high sugar diet. Aims The aim of this study was to examine the effects of treatment with EMPA on chemically induced colitis in mice fed a high sugar diet Methods At 6-8 weeks of age, wild-type 129/SvEv mice were placed on chow (CH) or high sugar diet (HS) (50% sucrose: AIN76A) ± EMPA (10mg/kg). After two days on the diet, mice were administered dextran sodium sulfate (DSS) for 5 days in drinking water followed by water alone for 2 days (n=4-6 mice for all groups). Disease activity index (DAI) was calculated daily from animal weight change, stool consistency, and stool hemoccult. As a measurement of degree of healing, colonic tissues were evaluated at day 9 for histological changes, weight-to-length ratio, and cytokine levels by ELISA. As a measure of EMPA functionality, urinary and blood glucose levels were measured. Results Mice on the HS diet demonstrated increased susceptibility to colitis compared with chow fed mice with increased colonic levels of IL-1β, weight loss, and DAI. Significant interactions between sex and diet were seen in responses to EMPA treatment. EMPA treatment did not alter severity of colitis but did significantly delay healing in male mice on both the HS and chow diets as evidenced by increased DAI and increased enterocyte injury with increased levels of lamina propria neutrophils and lymphocytes. EMPA treatment did not increase disease severity in females on either diet. No differences were seen in colonic TNFα, IL-10, IL-12p70, or IL-22 between any of the groups. Urinary glucose levels were elevated in mice receiving EMPA and significantly higher in males compared with females (pampersand:003C0.05). EMPA treatment did not alter fasting blood glucose levels. Conclusions A high sugar diet strongly exacerbates disease severity in a sex-dependent manner in a chemically induced model of colitis. Further, contrary to our hypothesis, EMPA treatment did not improve colitis in females and worsened disease in males suggesting that the documented anti-inflammatory effects of EMPA may be condition dependent. Funding Agencies CCC","PeriodicalId":508018,"journal":{"name":"Journal of the Canadian Association of Gastroenterology","volume":"33 8","pages":"219 - 219"},"PeriodicalIF":0.0,"publicationDate":"2024-02-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139778295","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A184 HCPE CONTRIBUTES TO THE HOST INFLAMMATORY RESPONSE TO HELICOBACTER PYLORI A184 HCPE有助于宿主对幽门螺旋杆菌的炎症反应
Pub Date : 2024-02-14 DOI: 10.1093/jcag/gwad061.184
C. Creuzenet, N. Salloum, J. Lester, J. M. Takougoum, D. Carroll, K Patel, C. Atanassov, C. Bodet, C. Burucoa
Abstract Background Helicobacter pylori (HP) colonizes chronically 50% of the world population, leading to gastric ulcers or cancers in 2-10 % of infections. Due to rising antibiotic resistance, curtailing HP-induced diseases requires the identification of new anti-HP molecules that can reduce HP viability or its ability to elicit inflammation. Amongst HP’s virulence factors are the Helicobacter Cysteine-rich Proteins (Hcp) that are secreted outside the bacteria and contain Sel-Like Repeats (SLR) which support protein / protein interactions involved in signal transduction across kingdoms. Several SLR-containing bacterial proteins including HcpA are involved in bacteria / host interactions. Thus, Hcps may affect HP’s virulence via interaction of their SLRs with host proteins. Aims We aim to elucidate the role of Hcps in HP’s virulence. Hcps were considered as immune decoys since anti-Hcp antibodies made in infected patients are unable to clear the infection. However, recent data suggest that Hcps interact with host components and may modulate the function of immune cells. However, their effects on gastric cells remain unknown and functional differences between Hcps remain to be explored. Methods This work uses knockout mutagenesis, interactions with gastric cells, transcriptomics, and microscopy. Results We focus on HcpE, the largest Hcp that may interact with many host proteins via its 9 SLRs motifs. We showed that HcpE is secreted outside HP in 2 lab strains and that ~ 30% of secreted HcpE was comprised in outer membrane vesicles that may deliver HcpE into eukaryotic cells by membrane fusion. We also showed that the DiSulfide Bond forming protein DsbK is essential for HcpE production and secretion. Here, we demonstrate the production and secretion of HcpE by clinical isolates in vitro, and its production in situ in infected patients. Using our HcpE and DsbK knockout mutants, we investigate the role of HcpE and other Hcps in interactions with human gastric cells in vitro and in ex vivo gastric explants, showing a role in inflammation activation. Finally, we demonstrate their role in murine gastric colonization and in murine splenocytes activation. Overall, our data show a role of Hcps in host / pathogen interactions largely due to immuno-modulatory functions and a role in gastric colonization, with a predominant role of HcpE over other Hcps. Conclusions The findings open up possibilities to use Hcps or the gate keeper DsbK that controls their production as novel therapeutic targets to alleviate the burden of HP-associated disease.This could benefit the ~6 million patients who develop gastric ulcers or cancers each year worldwide due to HP infection, also saving billions of annual health care costs. Funding Agencies Western University
摘要 背景幽门螺杆菌(HP)在全球 50%的人口中长期定植,2-10%的感染者会导致胃溃疡或癌症。由于抗生素耐药性的增加,要遏制幽门螺杆菌引发的疾病,就必须找到新的抗幽门螺杆菌分子,以降低幽门螺杆菌的生存能力或引发炎症的能力。HP的致病因子之一是富含半胱氨酸的螺旋杆菌蛋白(Hcp),它分泌于细菌外部,含有Sel-Like Repeats (SLR),支持蛋白质/蛋白质之间的相互作用,参与跨王国的信号转导。包括 HcpA 在内的几种含有 SLR 的细菌蛋白质参与了细菌与宿主之间的相互作用。因此,Hcps 可能通过其 SLR 与宿主蛋白的相互作用影响 HP 的毒力。目的 我们旨在阐明 Hcps 在 HP 毒力中的作用。Hcps 被认为是免疫诱饵,因为感染者体内产生的抗 Hcp 抗体无法清除感染。然而,最近的数据表明,Hcps 与宿主成分相互作用,可能会调节免疫细胞的功能。然而,它们对胃细胞的影响仍然未知,不同 Hcps 的功能差异也有待探索。方法 这项工作采用基因敲除诱变、与胃细胞相互作用、转录组学和显微镜技术。结果 我们重点研究了HcpE,它是最大的Hcp,可能通过其9个SLRs基序与许多宿主蛋白相互作用。我们发现,在 2 个实验室菌株中,HcpE 被分泌到 HP 外,约 30% 的分泌 HcpE 由外膜囊泡组成,这些囊泡可能通过膜融合将 HcpE 运送到真核细胞中。我们还发现,二硫键形成蛋白 DsbK 对 HcpE 的产生和分泌至关重要。在这里,我们展示了临床分离株在体外产生和分泌 HcpE 的情况,以及它在感染患者体内的原位产生情况。利用我们的 HcpE 和 DsbK 基因敲除突变体,我们研究了 HcpE 和其他 Hcps 在体外和体外胃外植体中与人胃细胞相互作用的作用,显示了它们在炎症激活中的作用。最后,我们证明了它们在小鼠胃定植和小鼠脾细胞活化中的作用。总之,我们的数据显示了 Hcps 在宿主与病原体相互作用中的作用,这主要归功于其免疫调节功能和在胃定植中的作用,其中 HcpE 比其他 Hcps 起主导作用。结论 这些发现为将 Hcps 或控制其产生的守门员 DsbK 作为新型治疗靶点以减轻 HP 相关疾病的负担提供了可能性。资助机构 美国西北大学
{"title":"A184 HCPE CONTRIBUTES TO THE HOST INFLAMMATORY RESPONSE TO HELICOBACTER PYLORI","authors":"C. Creuzenet, N. Salloum, J. Lester, J. M. Takougoum, D. Carroll, K Patel, C. Atanassov, C. Bodet, C. Burucoa","doi":"10.1093/jcag/gwad061.184","DOIUrl":"https://doi.org/10.1093/jcag/gwad061.184","url":null,"abstract":"Abstract Background Helicobacter pylori (HP) colonizes chronically 50% of the world population, leading to gastric ulcers or cancers in 2-10 % of infections. Due to rising antibiotic resistance, curtailing HP-induced diseases requires the identification of new anti-HP molecules that can reduce HP viability or its ability to elicit inflammation. Amongst HP’s virulence factors are the Helicobacter Cysteine-rich Proteins (Hcp) that are secreted outside the bacteria and contain Sel-Like Repeats (SLR) which support protein / protein interactions involved in signal transduction across kingdoms. Several SLR-containing bacterial proteins including HcpA are involved in bacteria / host interactions. Thus, Hcps may affect HP’s virulence via interaction of their SLRs with host proteins. Aims We aim to elucidate the role of Hcps in HP’s virulence. Hcps were considered as immune decoys since anti-Hcp antibodies made in infected patients are unable to clear the infection. However, recent data suggest that Hcps interact with host components and may modulate the function of immune cells. However, their effects on gastric cells remain unknown and functional differences between Hcps remain to be explored. Methods This work uses knockout mutagenesis, interactions with gastric cells, transcriptomics, and microscopy. Results We focus on HcpE, the largest Hcp that may interact with many host proteins via its 9 SLRs motifs. We showed that HcpE is secreted outside HP in 2 lab strains and that ~ 30% of secreted HcpE was comprised in outer membrane vesicles that may deliver HcpE into eukaryotic cells by membrane fusion. We also showed that the DiSulfide Bond forming protein DsbK is essential for HcpE production and secretion. Here, we demonstrate the production and secretion of HcpE by clinical isolates in vitro, and its production in situ in infected patients. Using our HcpE and DsbK knockout mutants, we investigate the role of HcpE and other Hcps in interactions with human gastric cells in vitro and in ex vivo gastric explants, showing a role in inflammation activation. Finally, we demonstrate their role in murine gastric colonization and in murine splenocytes activation. Overall, our data show a role of Hcps in host / pathogen interactions largely due to immuno-modulatory functions and a role in gastric colonization, with a predominant role of HcpE over other Hcps. Conclusions The findings open up possibilities to use Hcps or the gate keeper DsbK that controls their production as novel therapeutic targets to alleviate the burden of HP-associated disease.This could benefit the ~6 million patients who develop gastric ulcers or cancers each year worldwide due to HP infection, also saving billions of annual health care costs. Funding Agencies Western University","PeriodicalId":508018,"journal":{"name":"Journal of the Canadian Association of Gastroenterology","volume":"45 3","pages":"144 - 145"},"PeriodicalIF":0.0,"publicationDate":"2024-02-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139778387","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A59 EXPLORING THE ROLE OF ARID1A IN COLONIC HOMEOSTASIS AND REGENERATION A59 探索 arid1a 在结肠稳态和再生中的作用
Pub Date : 2024-02-14 DOI: 10.1093/jcag/gwad061.059
D. Lei, A. Loe, T Kim
Abstract Background Recent advances in cancer genome analysis have revealed frequently mutated epigenetic regulators as a novel feature in cancer development. Within this context, the Arid1a (AT-rich interactive domain-containing protein 1A) gene, a subunit of the BAF chromatin remodeling complex, has emerged as a frequently mutated gene in many cancers. Additionally, repeated colonic injury caused by diseases such as inflammatory bowel disease (IBD), is also a major risk factor leading to colorectal cancer. Therefore, understanding the connection between colonic epigenetic regulation and its role in response to injury is particularly important for understanding the pathobiology of colorectal cancer. Aims Aim 1: Exploring the role of Arid1a during colonic homeostasis. Mouse model with Arid1a conditionally knocked out in the colon will be analysed at different time points to test whether Arid1a is required during colonic homeostasis. Aim 2: Determining the role of Arid1a during colonic injury and regeneration. Mice will be exposed to a known colitis model to induce colonic injury. Arid1a will be deleted after injury to find out its role during regeneration and recovery from the injury. Methods To examine the effect of Arid1a loss on colonic homeostasis, mice between 6-10 weeks old were injected with 2mg/20g tamoxifen for three days to induce Arid1a knockout using the VilCreERT2; Arid1afl/fl mousseline. Mice were then euthanised using CO2 chamber and analysed 10 days, 3 weeks, and 8 weeks post Arid1a deletion. Histological analysis was performed to examine morphological changes in the colon. To examine the effect of Arid1a on injury caused by colitis, mice were treated with dextran sulfate sodium (DSS) to cause colitis-like injury. Then, Arid1a is deleted by injecting 2mg/20g tamoxifen. Changes in histology and specific cell types will be examined both in the short- and long-term. Results To test whether Arid1a loss alone causes morphological changes in the colon, I compared the crypt lengths between VilCreERT2; Arid1afl/fl mutant mice with their littermate controls and saw that there was no difference in both morphology and length of the crypts. My results show that Arid1a loss in the colon after injury resulted in impaired regeneration characterized by the prolonged loss of goblet cells and cryptal structure in the distal colon. In the long term, Arid1a loss before or after DSS treatment both lead to tumor formation, suggesting that Arid1a is required for colonic regeneration and repair while suppressing tumorigenesis. Conclusions Based on my results, I conclude that Arid1a deletion alone does not cause significant morphological changes in the colon, but this loss affects colonic regeneration and recovery compared to colons with Arid1a intact. In the long term, the dysregulated colonic regeneration may lead to tumorigenesis. Funding Agencies University of Toronto Department of Molecular Genetics
摘要 背景 癌症基因组分析的最新进展表明,表观遗传调控因子的频繁突变是癌症发展过程中的一个新特征。在此背景下,BAF染色质重塑复合物的一个亚基--Arid1a(富AT交互结构域含蛋白1A)基因成为许多癌症中频繁突变的基因。此外,炎症性肠病(IBD)等疾病引起的结肠反复损伤也是导致结直肠癌的主要风险因素。因此,了解结肠表观遗传调控之间的联系及其在损伤反应中的作用对于了解结直肠癌的病理生物学尤为重要。目的 1:探索 Arid1a 在结肠稳态过程中的作用。将在不同时间点分析结肠中被有条件敲除 Arid1a 的小鼠模型,以检验 Arid1a 在结肠稳态过程中是否是必需的。目标 2:确定 Arid1a 在结肠损伤和再生过程中的作用。小鼠将暴露于已知的结肠炎模型中,以诱导结肠损伤。损伤后将删除 Arid1a,以确定其在损伤再生和恢复过程中的作用。方法 为了研究 Arid1a 缺失对结肠稳态的影响,给 6-10 周大的小鼠注射 2mg/20g 他莫昔芬三天,用 VilCreERT2; Arid1afl/fl mousseline 诱导 Arid1a 基因敲除。然后使用二氧化碳室对小鼠实施安乐死,并在 Arid1a 基因缺失后 10 天、3 周和 8 周进行分析。进行组织学分析以检查结肠的形态变化。为了研究 Arid1a 对结肠炎引起的损伤的影响,用葡聚糖硫酸钠(DSS)处理小鼠以引起结肠炎样损伤。然后,通过注射 2 毫克/20 克他莫昔芬删除 Arid1a。将对组织学和特定细胞类型的短期和长期变化进行检测。结果 为了检验 Arid1a 的缺失是否会单独导致结肠的形态学变化,我比较了 VilCreERT2; Arid1afl/fl 突变小鼠和同窝对照小鼠的隐窝长度,结果发现隐窝的形态学和长度都没有差异。我的研究结果表明,结肠损伤后 Arid1a 的缺失会导致再生能力受损,其特征是远端结肠中的鹅口疮细胞和隐窝结构长期缺失。从长远来看,在DSS治疗前或治疗后缺失Arid1a都会导致肿瘤形成,这表明Arid1a是结肠再生和修复所必需的,同时抑制肿瘤发生。结论 根据我的研究结果,我得出结论:单独缺失 Arid1a 不会导致结肠发生显著的形态学变化,但与 Arid1a 完整的结肠相比,缺失 Arid1a 会影响结肠的再生和恢复。从长远来看,结肠再生失调可能会导致肿瘤发生。资助机构 多伦多大学分子遗传学系
{"title":"A59 EXPLORING THE ROLE OF ARID1A IN COLONIC HOMEOSTASIS AND REGENERATION","authors":"D. Lei, A. Loe, T Kim","doi":"10.1093/jcag/gwad061.059","DOIUrl":"https://doi.org/10.1093/jcag/gwad061.059","url":null,"abstract":"Abstract Background Recent advances in cancer genome analysis have revealed frequently mutated epigenetic regulators as a novel feature in cancer development. Within this context, the Arid1a (AT-rich interactive domain-containing protein 1A) gene, a subunit of the BAF chromatin remodeling complex, has emerged as a frequently mutated gene in many cancers. Additionally, repeated colonic injury caused by diseases such as inflammatory bowel disease (IBD), is also a major risk factor leading to colorectal cancer. Therefore, understanding the connection between colonic epigenetic regulation and its role in response to injury is particularly important for understanding the pathobiology of colorectal cancer. Aims Aim 1: Exploring the role of Arid1a during colonic homeostasis. Mouse model with Arid1a conditionally knocked out in the colon will be analysed at different time points to test whether Arid1a is required during colonic homeostasis. Aim 2: Determining the role of Arid1a during colonic injury and regeneration. Mice will be exposed to a known colitis model to induce colonic injury. Arid1a will be deleted after injury to find out its role during regeneration and recovery from the injury. Methods To examine the effect of Arid1a loss on colonic homeostasis, mice between 6-10 weeks old were injected with 2mg/20g tamoxifen for three days to induce Arid1a knockout using the VilCreERT2; Arid1afl/fl mousseline. Mice were then euthanised using CO2 chamber and analysed 10 days, 3 weeks, and 8 weeks post Arid1a deletion. Histological analysis was performed to examine morphological changes in the colon. To examine the effect of Arid1a on injury caused by colitis, mice were treated with dextran sulfate sodium (DSS) to cause colitis-like injury. Then, Arid1a is deleted by injecting 2mg/20g tamoxifen. Changes in histology and specific cell types will be examined both in the short- and long-term. Results To test whether Arid1a loss alone causes morphological changes in the colon, I compared the crypt lengths between VilCreERT2; Arid1afl/fl mutant mice with their littermate controls and saw that there was no difference in both morphology and length of the crypts. My results show that Arid1a loss in the colon after injury resulted in impaired regeneration characterized by the prolonged loss of goblet cells and cryptal structure in the distal colon. In the long term, Arid1a loss before or after DSS treatment both lead to tumor formation, suggesting that Arid1a is required for colonic regeneration and repair while suppressing tumorigenesis. Conclusions Based on my results, I conclude that Arid1a deletion alone does not cause significant morphological changes in the colon, but this loss affects colonic regeneration and recovery compared to colons with Arid1a intact. In the long term, the dysregulated colonic regeneration may lead to tumorigenesis. Funding Agencies University of Toronto Department of Molecular Genetics","PeriodicalId":508018,"journal":{"name":"Journal of the Canadian Association of Gastroenterology","volume":"65 38","pages":"38 - 39"},"PeriodicalIF":0.0,"publicationDate":"2024-02-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139778832","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A97 INTERNAL MEDICINE RESIDENT AND STAFF PERCEPTIONS OF GASTROENTEROLOGY ROTATION A97 内科住院医师和员工对胃肠病学轮转的看法
Pub Date : 2024-02-14 DOI: 10.1093/jcag/gwad061.097
N. K. Klemm, S. Jayakumar
Abstract Background The choice of subspecialty by internal medicine residents is partially influenced by their experience with that service. Challenges exist between internal medicine and the high acuity, procedurally-heavy, gastroenterology (GI) service. Negative perceptions may limit the number of residents rotating through a gastroenterology elective, impacting knowledge and comfort managing common GI conditions. Aims To identify misperceptions of the GI service at a tertiary hospital, and evaluate resident and new staff comfort in managing common GI conditions. Methods Twenty-question survey sent to internal medicine residents during 2022-2023 and 13-question survey sent to staff that completed training from 2020-2022; both anonymous, and using Qualtrics software. Results The survey was completed by 18% (30/166) of residents and 20% (13/65) of staff. Most staff (62%) practiced in a community setting. Both cohorts cited overnight cross-coverage consults during (56%) and negative word-of mouth (38%), as reasons they avoided a GI elective. Most participants reported a little (33%) or moderate (47%) amount of GI teaching on medicine service and were unaware of formal lectures (79%) during a GI rotation. Residents and staff were most comfortable managing pancreatitis (98%) and ALF (74%). Staff wished for more experience managing pancreatic and liver masses and outpatient IBD flares; however both groups (86%) were unaware of the ambulatory week during the GI rotation. Conclusions Misperception and unawareness of a GI elective persist amongst internal medicine residents and has implications for new staff managing GI conditions. This study has led to action items that address these concerns. Table 1: Resident & staff awareness, perceptions & knowledge of GI Resident Staff Reasons for not completing a GI rotation n=30 (%) n=9 (%) I had adequate experience completing GI consults overnight as Cross-Coverage 15 (50) 7 (78) GI service was too busy during the day 10 (33) 1 (11) I heard from other residents that is was not a good rotation 10 (33) 5 (56) I had not had a good experience with GI when on medicine service 7 (23) 2 (22) Aware of ambulatory week n=30 (%) n=12 (%) No 25 (83) 11 (92) Aware of formal lectures n=30 (%) n=12 (%) No 24 (80) 9 (75) Amount of teaching on GI conditions during medicine service n=30 (%) n=13 (%) None at all 2 (7) 0 A little 12 (40) 2 (15) A moderate amount 10 (33) 10 (77) A lot 6 (20) 0 A great deal 0 1 (8) During my first year as staff, I felt residency prepared me to manage the following GI issues n=13 (%) ALF or ACLF 11 (84) Liver Mass 5 (38) IBD flare - inpatient 3 (23) IBD flare - outpatient 0 Pancreatic mass 6 (46) Pancreatitis & complications 11 (84) Funding Agencies None
摘要 背景 内科住院医师对亚专科的选择部分受其服务经验的影响。内科与急诊量大、程序繁重的胃肠病学(GI)服务之间存在挑战。负面看法可能会限制通过消化内科选修课轮转的住院医师人数,影响他们对常见消化内科疾病的了解和管理舒适度。目的 找出对一家三级医院消化内科服务的误解,并评估住院医师和新员工在处理常见消化内科疾病时的舒适度。方法 对 2022-2023 年期间的内科住院医师进行 20 个问题的调查,对 2020-2022 年期间完成培训的员工进行 13 个问题的调查;调查均采用 Qualtrics 软件匿名进行。结果 18%的住院医师(30/166)和 20%的员工(13/65)完成了调查。大多数员工(62%)在社区环境中工作。两组人都认为,隔夜交叉会诊(56%)和负面口碑(38%)是他们避免选择消化内科手术的原因。大多数参与者表示,他们在医疗服务中接受了少量(33%)或中等量(47%)的消化内科教学,但并不知道在消化内科轮转期间有正式讲座(79%)。住院医师和员工在处理胰腺炎(98%)和 ALF(74%)时最得心应手。工作人员希望获得更多管理胰腺和肝脏肿块以及门诊 IBD 复发的经验;但两组人员(86%)都不知道在消化科轮转期间有门诊周。结论 内科住院医师对消化内科选修课的误解和不了解依然存在,这对管理消化内科疾病的新员工有一定影响。本研究提出了解决这些问题的行动项目。表 1:住院医师和医务人员的认识、表 1:住院医师和医务人员对消化内科的认识、看法和知识 住院医师 医务人员 不完成消化内科轮转的原因 n=30 (%) n=9 (%) 我有足够的经验在一夜之间完成消化内科会诊,作为交叉15 (50) 7 (78) 消化内科服务白天太忙 10 (33) 1 (11) 我听其他住院医师说这不是一个好的轮转 10 (33) 5 (56) 我在内科服务时没有很好的消化内科经验 7 (23) 2 (22) 了解门诊周 n=30 (%) n=12 (%) 否 25 (83) 11(92) 了解正式讲座 n=30 (%) n=12 (%) 否 24 (80) 9 (75) 内科服务期间消化道疾病的教学数量 n=30 (%) n=13 (%) 完全没有 2 (7) 0 少量 12 (40) 2 (15) 适量 10 (33) 10 (77) 大量 6 (20) 0 非常多 0 1 (8) 在我作为员工的第一年、我觉得住院医师培训使我能够处理以下消化道问题 n=13 (%) ALF 或 ACLF 11 (84) 肝包块 5 (38) IBD 爆发--住院病人 3 (23) IBD 爆发--门诊病人 0 胰腺包块 6 (46) 胰腺炎及并发症 11 (84) 资助机构 无
{"title":"A97 INTERNAL MEDICINE RESIDENT AND STAFF PERCEPTIONS OF GASTROENTEROLOGY ROTATION","authors":"N. K. Klemm, S. Jayakumar","doi":"10.1093/jcag/gwad061.097","DOIUrl":"https://doi.org/10.1093/jcag/gwad061.097","url":null,"abstract":"Abstract Background The choice of subspecialty by internal medicine residents is partially influenced by their experience with that service. Challenges exist between internal medicine and the high acuity, procedurally-heavy, gastroenterology (GI) service. Negative perceptions may limit the number of residents rotating through a gastroenterology elective, impacting knowledge and comfort managing common GI conditions. Aims To identify misperceptions of the GI service at a tertiary hospital, and evaluate resident and new staff comfort in managing common GI conditions. Methods Twenty-question survey sent to internal medicine residents during 2022-2023 and 13-question survey sent to staff that completed training from 2020-2022; both anonymous, and using Qualtrics software. Results The survey was completed by 18% (30/166) of residents and 20% (13/65) of staff. Most staff (62%) practiced in a community setting. Both cohorts cited overnight cross-coverage consults during (56%) and negative word-of mouth (38%), as reasons they avoided a GI elective. Most participants reported a little (33%) or moderate (47%) amount of GI teaching on medicine service and were unaware of formal lectures (79%) during a GI rotation. Residents and staff were most comfortable managing pancreatitis (98%) and ALF (74%). Staff wished for more experience managing pancreatic and liver masses and outpatient IBD flares; however both groups (86%) were unaware of the ambulatory week during the GI rotation. Conclusions Misperception and unawareness of a GI elective persist amongst internal medicine residents and has implications for new staff managing GI conditions. This study has led to action items that address these concerns. Table 1: Resident & staff awareness, perceptions & knowledge of GI Resident Staff Reasons for not completing a GI rotation n=30 (%) n=9 (%) I had adequate experience completing GI consults overnight as Cross-Coverage 15 (50) 7 (78) GI service was too busy during the day 10 (33) 1 (11) I heard from other residents that is was not a good rotation 10 (33) 5 (56) I had not had a good experience with GI when on medicine service 7 (23) 2 (22) Aware of ambulatory week n=30 (%) n=12 (%) No 25 (83) 11 (92) Aware of formal lectures n=30 (%) n=12 (%) No 24 (80) 9 (75) Amount of teaching on GI conditions during medicine service n=30 (%) n=13 (%) None at all 2 (7) 0 A little 12 (40) 2 (15) A moderate amount 10 (33) 10 (77) A lot 6 (20) 0 A great deal 0 1 (8) During my first year as staff, I felt residency prepared me to manage the following GI issues n=13 (%) ALF or ACLF 11 (84) Liver Mass 5 (38) IBD flare - inpatient 3 (23) IBD flare - outpatient 0 Pancreatic mass 6 (46) Pancreatitis & complications 11 (84) Funding Agencies None","PeriodicalId":508018,"journal":{"name":"Journal of the Canadian Association of Gastroenterology","volume":"222 ","pages":"69 - 71"},"PeriodicalIF":0.0,"publicationDate":"2024-02-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139836474","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A141 RISK OF TOTAL METACHRONOUS ADVANCED NEOPLASIA AFTER DETECTION OF PROXIMAL HYPERPLASTIC POLYPS, ADENOMAS, AND THEIR COMBINATION A141 在检测到近端增生性息肉、腺瘤及其合并症后,发生全部晚期肿瘤的风险
Pub Date : 2024-02-14 DOI: 10.1093/jcag/gwad061.141
W. Safih, D. von Renteln, I. Popescu Crainic, C. Haumesser, B. Noyon, F. Mubaid, C. Rekkabi, P. Marques, Y Li, R. Djinbachian
Abstract Background Recent research findings have identified an association between proximal sessile serrated lesions (SSL) and a greater risk of advanced metachronous neoplasia, without significant impact of distal SSL. Aims The principal aim of this study was to assess the risk of total metachronous advanced neoplasia (T-MAN) at the follow-up (fu) colonoscopy after detection of proximal hyperplastic polyps (HP), adenomas and their combination at the initial colonoscopy. Methods Medical records for patients aged 45 to 74 who underwent colonoscopies in both 2014 and 2015 were reviewed. The primary outcome was the presence of T-MAN (comprising advanced adenomas or high-risk SL) during the follow-up colonoscopy depending on the presence of proximal HP, adenoma, or their combination at index colonoscopy. Secondary outcomes included assessing the risk of T-MAN at follow-up depending on index findings characteristics. Results 2014 patients were screened and 764 were included in the final analysis (44.1% male vs 55.9% female; mean age, 63y; median follow-up, 3.46 years). Patients with both proximal hyperplastic polyps and colonic adenomas during their initial colonoscopy had a significantly higher risk of developing T-MAN than patients with a combination of adenomas and distal HP or with only adenomas at index colonoscopy (30.5% vs 19%) [Hazard-ratio (HR)=1.95 (95% confidence interval (CI)1.3-2.9)]. A combination of proximal hyperplastic polyps and colonic adenomas is associated with a higher risk of T-MAN during follow-up than proximal HP alone (30.5% vs 13.9%) [HR=3.4 (95% CI 1.3-8.7)]. No statistically significant evidence was found to identify an increased risk of developing T-MAN at follow-up in patients presenting adenomas alone vs those with only proximal HP (19.1% vs 13.9%) [HR=1.9 (95% CI 0.75-4.7)]. Conclusions Patients with proximal hyperplastic polyps have an increased risk of presenting a T-MAN at the follow-up colonoscopy. Presenting a combination of hyperplastic polyps and adenomas indicates a higher risk of developing T-MAN than presenting an HP or adenoma alone. Funding Agencies Daniel von Renteln is supported by a "Fonds de Recherche du Québec Santé" career development award. He has also received research funding from ERBE Elektromedizin GmbH, Ventage, Pendopharm, Fujifilm and Pentax, and has received consultant or speaker fees from Boston Scientific Inc., ERBE Elektromedizin GmbH, and Pendopharm. Roupen Djinbachian is supported by a “Fonds de Recherche du Québec Santé/Ministère de la Santé et des Services Sociaux” clinical research award. The remaining authors declare that they have no conflict of interest.
摘要 背景 最近的研究发现,近端无柄锯齿状病变(SSL)与晚期间变性肿瘤的风险增加有关,而远端 SSL 没有明显影响。目的 本研究的主要目的是评估在初次结肠镜检查中发现近端增生性息肉(HP)、腺瘤及其合并症后,在后续结肠镜检查中发生全晚期肿瘤(T-MAN)的风险。方法 回顾2014年和2015年接受结肠镜检查的45至74岁患者的医疗记录。主要结果是随访结肠镜检查时是否出现T-MAN(包括晚期腺瘤或高危SL),取决于首次结肠镜检查时是否出现近端HP、腺瘤或它们的组合。次要结果包括根据索引结果特征评估随访时出现 T-MAN 的风险。结果 2014 例患者接受了筛查,764 例纳入最终分析(男性占 44.1%,女性占 55.9%;平均年龄 63 岁;中位随访时间 3.46 年)。在初次结肠镜检查中同时发现近端增生性息肉和结肠腺瘤的患者,其罹患T-MAN的风险明显高于同时发现腺瘤和远端HP或在初次结肠镜检查中仅发现腺瘤的患者(30.5% vs 19%)[危险比(HR)=1.95(95% 置信区间(CI)1.3-2.9)]。在随访期间,近端增生性息肉和结肠腺瘤的组合与较高的 T-MAN 风险相关,而仅近端 HP 的组合则与较高的 T-MAN 风险相关(30.5% 对 13.9%)[HR=3.4(95% 置信区间 1.3-8.7)]。对于仅有腺瘤的患者与仅有近端HP的患者(19.1% vs 13.9%)[HR=1.9 (95% CI 0.75-4.7)],没有发现有统计学意义的证据表明随访期间发生T-MAN的风险增加。结论 患有近端增生性息肉的患者在后续结肠镜检查中出现 T-MAN 的风险增加。同时患有增生性息肉和腺瘤的患者比单纯患有增生性息肉或腺瘤的患者患 T-MAN 的风险更高。资助机构 丹尼尔-冯-伦特恩(Daniel von Renteln)获得了 "魁北克健康研究基金会"(Fonds de Recherche du Québec Santé)的职业发展奖。他还从 ERBE Elektromedizin GmbH、Ventage、Pendopharm、Fujifilm 和 Pentax 获得研究经费,并从 Boston Scientific Inc.、ERBE Elektromedizin GmbH 和 Pendopharm 获得顾问费或演讲费。Roupen Djinbachian 得到了 "魁北克卫生研究基金/卫生和社会服务部 "临床研究奖的支持。其余作者声明不存在利益冲突。
{"title":"A141 RISK OF TOTAL METACHRONOUS ADVANCED NEOPLASIA AFTER DETECTION OF PROXIMAL HYPERPLASTIC POLYPS, ADENOMAS, AND THEIR COMBINATION","authors":"W. Safih, D. von Renteln, I. Popescu Crainic, C. Haumesser, B. Noyon, F. Mubaid, C. Rekkabi, P. Marques, Y Li, R. Djinbachian","doi":"10.1093/jcag/gwad061.141","DOIUrl":"https://doi.org/10.1093/jcag/gwad061.141","url":null,"abstract":"Abstract Background Recent research findings have identified an association between proximal sessile serrated lesions (SSL) and a greater risk of advanced metachronous neoplasia, without significant impact of distal SSL. Aims The principal aim of this study was to assess the risk of total metachronous advanced neoplasia (T-MAN) at the follow-up (fu) colonoscopy after detection of proximal hyperplastic polyps (HP), adenomas and their combination at the initial colonoscopy. Methods Medical records for patients aged 45 to 74 who underwent colonoscopies in both 2014 and 2015 were reviewed. The primary outcome was the presence of T-MAN (comprising advanced adenomas or high-risk SL) during the follow-up colonoscopy depending on the presence of proximal HP, adenoma, or their combination at index colonoscopy. Secondary outcomes included assessing the risk of T-MAN at follow-up depending on index findings characteristics. Results 2014 patients were screened and 764 were included in the final analysis (44.1% male vs 55.9% female; mean age, 63y; median follow-up, 3.46 years). Patients with both proximal hyperplastic polyps and colonic adenomas during their initial colonoscopy had a significantly higher risk of developing T-MAN than patients with a combination of adenomas and distal HP or with only adenomas at index colonoscopy (30.5% vs 19%) [Hazard-ratio (HR)=1.95 (95% confidence interval (CI)1.3-2.9)]. A combination of proximal hyperplastic polyps and colonic adenomas is associated with a higher risk of T-MAN during follow-up than proximal HP alone (30.5% vs 13.9%) [HR=3.4 (95% CI 1.3-8.7)]. No statistically significant evidence was found to identify an increased risk of developing T-MAN at follow-up in patients presenting adenomas alone vs those with only proximal HP (19.1% vs 13.9%) [HR=1.9 (95% CI 0.75-4.7)]. Conclusions Patients with proximal hyperplastic polyps have an increased risk of presenting a T-MAN at the follow-up colonoscopy. Presenting a combination of hyperplastic polyps and adenomas indicates a higher risk of developing T-MAN than presenting an HP or adenoma alone. Funding Agencies Daniel von Renteln is supported by a \"Fonds de Recherche du Québec Santé\" career development award. He has also received research funding from ERBE Elektromedizin GmbH, Ventage, Pendopharm, Fujifilm and Pentax, and has received consultant or speaker fees from Boston Scientific Inc., ERBE Elektromedizin GmbH, and Pendopharm. Roupen Djinbachian is supported by a “Fonds de Recherche du Québec Santé/Ministère de la Santé et des Services Sociaux” clinical research award. The remaining authors declare that they have no conflict of interest.","PeriodicalId":508018,"journal":{"name":"Journal of the Canadian Association of Gastroenterology","volume":"126 ","pages":"108 - 109"},"PeriodicalIF":0.0,"publicationDate":"2024-02-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139836492","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of the Canadian Association of Gastroenterology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1